-
Posted by
Two Blokes Thu at 11:30 PM -
Filed in
Stock
-
0 views
BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.71 per share a year ago.
